SCHEMBL7611057

SCHEMBL7611057

C#Cc1ccc(C(=O)O)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HA1 P13674 3/20 0.57
P4HTM Q9NXG6 2/20 0.57
MIF P14174 1/20 0.55
GABRP O00591 1/20 0.53
GABRD O14764 1/20 0.53
GABRA1 P14867 1/20 0.53
GABRB1 P18505 1/20 0.53
GABRG2 P18507 1/20 0.53
GABRB3 P28472 1/20 0.53
GABRA5 P31644 1/20 0.53
GABRA3 P34903 1/20 0.53
GABRA2 P47869 1/20 0.53
GABRB2 P47870 1/20 0.53
GABRA4 P48169 1/20 0.53
GABRE P78334 1/20 0.53
GABRA6 Q16445 1/20 0.53
GABRG1 Q8N1C3 1/20 0.53
GABRG3 Q99928 1/20 0.53
GABRQ Q9UN88 1/20 0.53
NAPRT Q6XQN6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31371654 1.00 P4HA1 (0.57) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL5163246 0.83 P4HA1 (0.57) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL65165 0.82 P4HA1 (0.55) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL31281693 0.82 P4HA1 (0.55) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL4271680 0.82 GRM5 (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL18104362 0.82 KCNJ1 (0.44) P4HA1P4HTMMIFHPGDMAPT
SCHEMBL29470888 0.80 P4HA1 (0.48) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL565225 0.79 P4HA1 (0.52) P4HA1P4HTMMIFGABRPGABRD
SCHEMBL4550568 0.77 MAPK1 (0.61) ALDH1A1MAPTGRM5TSHR
SCHEMBL22701684 0.77 MAPT (0.42) HPGDHCAR3MAPTGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1700855-B1 A process for the preparation of tazarotene FIDIA FARMACEUTICI (IT) 2015-05-06 EP claimed
CN-114763346-B Compounds for inducing cartilage formation and application thereof 华东师范大学 2025-06-10 CN disclosed
CN-112384502-B Cycloalkyl-substituted amide derivatives, preparation method and medical application thereof 上海海雁医药科技有限公司 2022-11-08 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-112384502-A Cycloalkyl-substituted amide derivatives, preparation method and medical application thereof 上海海雁医药科技有限公司 2021-02-19 CN disclosed
WO-2020147582-A1 AMIDE DERIVATIVE SUBSTITUTED BY CYCLOALKYL, PREPARATION METHOD FOR AMIDE DERIVATIVE, AND USE IN MEDICINE 上海海雁医药科技有限公司 2020-07-23 WO disclosed
EP-0952975-B1 BI-AROMATIC COMPOUNDS BOUND BY A HETEROETHYNYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME GALDERMA RES & DEV (FR) 2002-07-10 EP disclosed
EP-0879814-B1 Triaromatic compounds, compositions containing them and uses thereof CT INTERNAT DE BR RECH S DERMA (FR) 2001-11-28 EP disclosed
EP-0952975-A1 BI-AROMATIC COMPOUNDS BOUND BY A HETEROETHYNYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME Galderma Research & Development (FR) 1999-11-03 EP disclosed
WO-1999010322-A1 BI-AROMATIC COMPOUNDS BOUND BY A HETEROETHYNYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME GALDERMA RESEARCH & DEVELOPMENT (FR) 1999-03-04 WO disclosed
EP-0879814-A1 Triaromatic compounds, compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1998-11-25 EP disclosed